Wieland H. Sommer1, Felix Ceelen1, Philipp M. Paprottka1, Maximilian F. Reiser1, Daniel Theisen1
1Department of Clinical Radiology, University of Munich, Grohadern Hospital, Munich, Bavaria, Germany
The aim of this study was to define the role of MRI in the pretherapeutic prediction of treatment response of radioembolization in neuroendocrine liver metastases. By analyzing different combinations of predictors at baseline and correlation them with the survival, we defined vascularization, histologic markers as the most valuable predictors. Progression free survival is independent of the tumor load in the liver.
Keywords